Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid In Capital
Treasury Stock
Accumulated Deficit
Total The Joint Corp. stockholders' equity
Non-controlling interest
Balance at Dec. 31, 2018 $ 727,601 $ 13,757 $ 38,189,251 $ (90,856) $ (37,384,651) $ 727,501 $ 100
Balance (in shares) at Dec. 31, 2018   13,757,200   (14,670)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 171,771   171,771     171,771  
Exercise of stock options (in shares)   42,804          
Exercise of stock options 220,244 $ 43 220,201     220,244  
Net income 952,646       952,646 952,646  
Balance at Mar. 31, 2019 2,072,262 $ 13,800 38,581,223 $ (90,856) (36,432,005) 2,072,162 100
Balance (in shares) at Mar. 31, 2019   13,800,004   (14,670)      
Balance at Dec. 31, 2018 727,601 $ 13,757 38,189,251 $ (90,856) (37,384,651) 727,501 100
Balance (in shares) at Dec. 31, 2018   13,757,200   (14,670)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 2,031,887            
Balance at Sep. 30, 2019 3,803,808 $ 13,895 39,253,617 $ (111,040) (35,352,764) 3,803,708 100
Balance (in shares) at Sep. 30, 2019   13,894,621   (15,762)      
Balance at Mar. 31, 2019 2,072,262 $ 13,800 38,581,223 $ (90,856) (36,432,005) 2,072,162 100
Balance (in shares) at Mar. 31, 2019   13,800,004   (14,670)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 178,953   178,953     178,953  
Issuance of restricted stock (in shares)   33,012          
Issuance of restricted stock 0 $ 33 (33)        
Exercise of stock options (in shares)   5,000          
Exercise of stock options 19,400 $ 5 19,395     19,400  
Net income 462,261       462,261 462,261  
Balance at Jun. 30, 2019 2,732,876 $ 13,838 38,779,538 $ (90,856) (35,969,744) 2,732,776 100
Balance (in shares) at Jun. 30, 2019   13,838,016   (14,670)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 186,020   186,020     186,020  
Issuance of restricted stock (in shares)   5,277          
Issuance of restricted stock 0 $ 5 (5)        
Exercise of stock options (in shares)   51,328          
Exercise of stock options 288,116 $ 52 288,064     288,116  
Purchase of treasury stock under employee stock plans (in shares)       1,092      
Purchases of treasury stock under employee stock plans (20,184)     $ (20,184)   (20,184)  
Net income 616,980       616,980 616,980  
Balance at Sep. 30, 2019 3,803,808 $ 13,895 39,253,617 $ (111,040) (35,352,764) 3,803,708 100
Balance (in shares) at Sep. 30, 2019   13,894,621   (15,762)      
Balance at Dec. 31, 2019 5,720,500 $ 13,899 39,454,937 $ (111,041) (33,637,395) 5,720,400 100
Balance (in shares) at Dec. 31, 2019   13,898,694   (15,762)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 250,392   250,392     250,392  
Issuance of restricted stock (in shares)   15,578          
Issuance of restricted stock 0 $ 16 (16)        
Exercise of stock options (in shares)   35,500          
Exercise of stock options 140,899 $ 35 140,864     140,899  
Purchase of treasury stock under employee stock plans (in shares)       251      
Purchases of treasury stock under employee stock plans (3,774)     $ (3,774)   (3,774)  
Net income 814,947       814,947 814,947  
Balance at Mar. 31, 2020 6,922,964 $ 13,950 39,846,177 $ (114,815) (32,822,448) 6,922,864 100
Balance (in shares) at Mar. 31, 2020   13,949,772   (16,013)      
Balance at Dec. 31, 2019 5,720,500 $ 13,899 39,454,937 $ (111,041) (33,637,395) 5,720,400 100
Balance (in shares) at Dec. 31, 2019   13,898,694   (15,762)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 2,534,491            
Balance at Sep. 30, 2020 9,421,093 $ 14,073 40,625,128 $ (115,303) (31,102,905) 9,420,993 100
Balance (in shares) at Sep. 30, 2020   14,073,244   (16,043)      
Balance at Mar. 31, 2020 6,922,964 $ 13,950 39,846,177 $ (114,815) (32,822,448) 6,922,864 100
Balance (in shares) at Mar. 31, 2020   13,949,772   (16,013)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 216,081   216,081     216,081  
Issuance of restricted stock (in shares)   30,882          
Issuance of restricted stock 0 $ 31 (31)        
Exercise of stock options (in shares)   62,200          
Exercise of stock options 247,021 $ 62 246,959     247,021  
Net income 115,584       115,584 115,584  
Balance at Jun. 30, 2020 7,501,650 $ 14,043 40,309,186 $ (114,815) (32,706,864) 7,501,550 100
Balance (in shares) at Jun. 30, 2020   14,042,854   (16,013)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 212,234   212,234     212,234  
Issuance of restricted stock (in shares)   4,281          
Issuance of restricted stock 0 $ 4 (4)        
Exercise of stock options (in shares)   26,109          
Exercise of stock options 103,738 $ 26 103,712     103,738  
Purchase of treasury stock under employee stock plans (in shares)       30      
Purchases of treasury stock under employee stock plans (488)     $ (488)   (488)  
Net income 1,603,959       1,603,959 1,603,959  
Balance at Sep. 30, 2020 $ 9,421,093 $ 14,073 $ 40,625,128 $ (115,303) $ (31,102,905) $ 9,420,993 $ 100
Balance (in shares) at Sep. 30, 2020   14,073,244   (16,043)